Does the Enhanced Rehabilitation Programs Facilitate the Motor Recovery After Stroke?

September 30, 2019 updated by: Yen-Nung Lin, Taipei Medical University WanFang Hospital

Does the Enhanced Rehabilitation Programs Facilitate the Motor Recovery After Stroke? A Multicenter Randomized Controlled Study (TIARAS Trial)

Study purpose This study will explore whether an additional rehabilitation program that focus on either upper or lower extremity training facilitate the recovery in upper or lower extremity.

The recovery in both neurological status and motor functions will be explored.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

Design A single-blinded (assessor-blinded) randomized controlled trial. Interventions The participants will be randomly assigned into two experiment groups (enhanced upper extremity program; and enhanced lower-extremity program).

Both groups receive routine rehabilitation including daily 50 mins of physical therapy and 50 mins of occupational therapy.

The enhanced upper extremity program group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity, while the enhanced lower-extremity program group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity. The participants receive 20-day training over a 4-week period. The additional program is designed to be specific to either upper-extremity or lower-extremity. Accordingly, one group can be used as the control group of the other one.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • New Taipei City, Taiwan
        • WanFang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. First-ever stroke with the onset 10-90 days prior to the enrollment
  2. Age: 20-80y
  3. With a hemiplegic upper extremity with Brunnstrom stage in I~IV
  4. Able to understand simple orders (1-step orders, such as "raise your hand, touch your head….)
  5. Totally independent in activity of daily life before the onset of stroke

Exclusion Criteria:

  1. Incompliance to the assessments or interventions due to unstable medical condition, abnormal cognition, or other conditions.
  2. Stroke of brainstem or cerebellum
  3. Had received craniotomy or ventriculoperitoneal shunting
  4. Needs of orthoses in walking before the onset of stroke
  5. Had had motor dysfunctions (eg, amputation, cerebral palsy, poliomyelitis or other neuromuscular diseases) before the stroke.
  6. Intracranial hemorrhage caused by artereovenous malformation, aneurysm, or tumor
  7. Able to walk independently for more than 50 meters.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: enhanced upper-extremity program, EUEP

Both groups receive routine rehabilitation including daily 50 mins of physical therapy and 50 mins of occupational therapy.

The EUP group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity.

The participants receive 20-day training over a 4-weekperiod. The additional program is designed to be specific to either upper-extremity or lower-extremity.

Accordingly, one group can be used as the control group of the other one.

The EUEP group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity,
Experimental: enhanced lower-extremity program,ELLP)

Both groups receive routine rehabilitation including daily 50 mins of physical therapy and 50 mins of occupational therapy.

The ELP group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity.

The participants receive 20-day training over a4-weekperiod. The additional program is designed to be specific to either upper-extremity or lower-extremity.

Accordingly,one group can be used as the control group of the other one.

The ELEP group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment (upper extremity subscale)
Time Frame: 0-, 4- week
The primary outcome is the change from baseline upper extremity subscale of Fugl-Meyer assessment at the end to 4-wk (post-intervention).
0-, 4- week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Action Research Arm Test (ARAT)
Time Frame: 0-, 4-, 8-, 12-, 24 week
A test that measures the upper extremity motor functions after the stroke.
0-, 4-, 8-, 12-, 24 week
Berg Balance Test
Time Frame: 0-, 4-, 8-, 12-, 24 week
A test that measures the balance functions.
0-, 4-, 8-, 12-, 24 week
Fugl-Meyer Assessment (lower extremity subscale)
Time Frame: 0-, 4-, 8-, 12-, 24 week
The FMA-LE (0-34) measures the lower extremity motor functions after the stroke.
0-, 4-, 8-, 12-, 24 week
Fugl-Meyer Assessment (upper extremity subscale)
Time Frame: 0-, 4-, 8-, 12-, 24 week
FMA-UE (0-66), the subscale of FMA that measures the poststroke neuro-motor functions.
0-, 4-, 8-, 12-, 24 week
Time required for 10 meter walking
Time Frame: 0-, 4-, 8-, 12-, 24 week
measuring the walking speed over a 10-meter distance
0-, 4-, 8-, 12-, 24 week
Stroke Impact Scale
Time Frame: 0-, 4-, 8-, 12-, 24 week
A measure for stroke-specific quality of life
0-, 4-, 8-, 12-, 24 week
Barthel Index
Time Frame: 0-, 4-, 8-, 12-, 24 week
to measure the activity of daily living
0-, 4-, 8-, 12-, 24 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2018

Primary Completion (Anticipated)

May 20, 2020

Study Completion (Anticipated)

May 20, 2020

Study Registration Dates

First Submitted

July 20, 2017

First Submitted That Met QC Criteria

July 25, 2017

First Posted (Actual)

July 26, 2017

Study Record Updates

Last Update Posted (Actual)

October 3, 2019

Last Update Submitted That Met QC Criteria

September 30, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • N201705071

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Poststroke/CVA Hemiparesis

Clinical Trials on UFT

3
Subscribe